Frankfurt
22.05.26 | 15:25
0,111 Euro
-2,63 % -0,003
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | LEE'S PHARM (00950): ANNUAL GENERAL MEETING HELD ON 21 MAY 2026 - POLL RESULTS | 1 | HKEx | ||
| 11.05. | LEE'S PHARM (00950): CONNECTED TRANSACTION - INVESTMENT IN PARTNERSHIP FUND | 1 | HKEx | ||
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 24.04. | LEE'S PHARM (00950): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 2 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): PROXY FORM | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 1 | HKEx | ||
| 23.04. | LEE'S PHARM (00950): ANNUAL REPORT 2025 | - | HKEx | ||
| 30.03. | LEE'S PHARM (00950): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 | 1 | HKEx | ||
| 30.03. | Lee's Pharmaceutical Holdings Ltd. Reports Retreat In Full Year Bottom Line | 1 | RTTNews | ||
| 30.03. | LEE'S PHARM (00950): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 25.03. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - APPROVAL OF INTRAROSA BY NMPA | - | HKEx | ||
| 17.03. | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 5 | HKEx | ||
| 27.01. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ADASUVE | - | HKEx | ||
| 22.12.25 | LEE'S PHARM (00950): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 5 | HKEx | ||
| 18.12.25 | LEE'S PHARM (00950): PASSING AWAY OF MICHELE DALLA LIBERA | 1 | HKEx | ||
| 11.12.25 | Lee's Pharmaceutical Holdings Limited: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 624 | PR Newswire | Acquisition of Staccato One Breath Technology, a proprietary platform technology with broad therapeutic potentialSynergistic and complementary to Lee's Pharm's existing products pipeline... ► Artikel lesen | |
| 11.12.25 | Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 418 | PR Newswire | Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential
Synergistic and complementary to Lee's Pharm's existing products... ► Artikel lesen | |
| 08.12.25 | LEE'S PHARM (00950): DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 1 | HKEx |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 115,78 | +0,02 % | Gilead Gets Positive CHMP Opinion For Trodelvy In First-Line Metastatic TNBC | FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization for Trodelvy... ► Artikel lesen | |
| ZOETIS | 70,14 | +0,11 % | Stifel senkt Kursziel für Zoetis wegen Wettbewerbsdruck | ||
| SINOPHARM | 1,920 | -1,41 % | Sinopharm expands its international presence | ||
| CSPC PHARMA | 0,836 | -1,41 % | CSPC PHARMA Ustekinumab Injection Approved for Market Launch | ||
| WUXI BIOLOGICS | 3,570 | +0,85 % | WUXI BIO (02269): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 10, 2026 | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 1,892 | 0,00 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY | ||
| GEDEON RICHTER | 34,040 | +0,71 % | Gedeon Richter Plc.: Strategic Partnerships in Focus: Gedeon Richter at Chessparty Stockholm | BUDAPEST, Hungary, May 5, 2026 /PRNewswire/ -- Gedeon Richter was proud to be represented at Chessparty, the renowned chess festival held on April 17th-18th at Stockholm's Avicii Arena, marking... ► Artikel lesen | |
| DR REDDYS | 11,600 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| MEDIPHARM LABS | 0,047 | -9,71 % | MediPharm Labs Corp.: MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA | Q1 2026 Positive Adjusted EBITDA(1)Net Revenue of $9M with strong gross margins of 37%OPEX decreased 28% in Q1 2026 versus Q4 2025Company is virtually debt free, with a Q1 ending cash balance of $9.9... ► Artikel lesen | |
| ASPEN PHARMACARE | 7,000 | +1,45 % | ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Director and Prescribed Officer | ||
| SHANGHAI PHARMACEUTICALS | 1,350 | +3,85 % | Dividendenbekanntmachungen (29.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 6,35 JPY 0,0344 EUR AGC INC JP3112000009 105 JPY 0,5701 EUR AMERICAN TOWER CORPORATION US03027X1000 1... ► Artikel lesen | |
| LUYE PHARMA | 0,246 | 0,00 % | LUYE PHARMA (02186): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,107 | 0,00 % | Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen und Sihuan Pharmaceutical kündigen strategische Partnerschaft auf dem Gebiet der Gewichtsreduktion und darüber hinaus an | Biocytogen Pharmaceuticals (Peking) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), ein weltweit tätiges Biotechnologieunternehmen, das die Forschung und Entwicklung neuartiger, Antikörper-basierter... ► Artikel lesen | |
| CHINA RESOURCES PHARMACEUTICAL | 0,505 | 0,00 % | CHINARES PHARMA (03320): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) | ||
| HANSOH PHARMACEUTICAL | 3,650 | -1,24 % | HSCEI Adds HANSOH PHARMA and AKESO, Removes SUNNY OPTICAL and HAIER SMARTHOME in Quarterly Review |
LEES PHARMACEUTICAL HOLDINGS LTD gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,111 Euro und damit -2,63 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LEES PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.